Page last updated: 2024-09-23

disparlure

Description

disparlure: RN given refers to cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID62850
CHEBI ID179293
SCHEMBL ID2855219
MeSH IDM0041242

Synonyms (55)

Synonym
CHEBI:179293
2-methyl-7s,8r-epoxy-octadecane
29804-22-6
(2r,3s)-2-decyl-3-(5-methylhexyl)oxirane
(1)-cis-7,8-epoxy-2-methyloctadecane
(+-)-cis-disparlure
caswell no. 424a
disparlure (2s-cis)
octadecane, 7,8-epoxy-2-methyl-, cis-
(+-)-disparlure
ent 34886
cis-2-decyl-3-(5-methylhexyl)oxirane
einecs 260-747-5
ai3-34886
atralymon
oxirane, 2-decyl-3-(5-methylhexyl)-, (2r,3s)-rel-
disparlure
epoxan
oxirane, 2-decyl-3-(5-methylhexyl)-, cis-
einecs 249-861-6
(z)-7,8-epoxy-2-methyloctadecane
cis-7,8-epoxy-2-methyloctadecane
epa pesticide chemical code 114301
LMFA12000283
unii-1fu18g2315
1fu18g2315 ,
AKOS015913140
disparlure, cis-(+/-)-
(2r,3s)-rel-2-decyl-3-(5-methylhexyl)oxirane
disparlure (+/-)-cis-form [mi]
disrupt ii gm
(7rs,8sr)-7,8-epoxy-2-methyloctadecane
ent-34886
7,8-epoxy-2-methyloctadecane, cis-
SCHEMBL2855219
E5FWS893X3 ,
oxirane, 2-decyl-3-(5-methylhexyl)-, (2r,3s)-
disparlure, (-)-
(-)-disparlure
7s-cis-disparlure
cis-(-)-disparlure
disparlure, cis-(-)-
54910-52-0
(7s,8r)-(-)-disparlure
unii-e5fws893x3
2-decyl-3-(5-methylhexyl)oxirane, (z)-
HFOFYNMWYRXIBP-MOPGFXCFSA-N
(.+/-cis-7,8-epoxy-2-methyloctadecane
(.+/-.)-cis-disparlure
DTXSID4035548
(7s,8r)-cis-7,8-epoxy-2-methyloctadecane
Q1229127
cis-(7s,8r)-(-)-epoxy-2-methyloctadecane
GLXC-26572
disparlure 100 microg/ml in acetonitrile

Drug Classes (1)

ClassDescription
epoxideAny cyclic ether in which the oxygen atom forms part of a 3-membered ring.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (20)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's11 (55.00)29.6817
2010's8 (40.00)24.3611
2020's1 (5.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other20 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]